- Home
- DNLI vs NBTB Comparison
DNLI vs NBTB Comparison
Compare DNLI & NBTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- NBTB
- Stock Information
- Founded
- DNLI 2013
- NBTB 1856
- Country
- DNLI United States
- NBTB United States
- Employees
- DNLI N/A
- NBTB N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- NBTB Major Banks
- Sector
- DNLI Health Care
- NBTB Finance
- Exchange
- DNLI Nasdaq
- NBTB Nasdaq
- Market Cap
- DNLI 2.5B
- NBTB 2.3B
- IPO Year
- DNLI 2017
- NBTB N/A
- Fundamental
- Price
- DNLI $19.09
- NBTB $42.75
- Analyst Decision
- DNLI Strong Buy
- NBTB Buy
- Analyst Count
- DNLI 13
- NBTB 3
- Target Price
- DNLI $32.64
- NBTB $52.33
- AVG Volume (30 Days)
- DNLI 1.4M
- NBTB 217.8K
- Earning Date
- DNLI 11-06-2025
- NBTB 10-27-2025
- Dividend Yield
- DNLI N/A
- NBTB 3.50%
- EPS Growth
- DNLI N/A
- NBTB 5.89
- EPS
- DNLI N/A
- NBTB 3.02
- Revenue
- DNLI N/A
- NBTB $629,728,000.00
- Revenue This Year
- DNLI N/A
- NBTB $27.05
- Revenue Next Year
- DNLI $94,232.03
- NBTB $10.49
- P/E Ratio
- DNLI N/A
- NBTB $14.02
- Revenue Growth
- DNLI N/A
- NBTB 16.88
- 52 Week Low
- DNLI $10.57
- NBTB $37.31
- 52 Week High
- DNLI $26.18
- NBTB $52.44
- Technical
- Relative Strength Index (RSI)
- DNLI 69.43
- NBTB 60.81
- Support Level
- DNLI $16.85
- NBTB $39.52
- Resistance Level
- DNLI $18.21
- NBTB $41.77
- Average True Range (ATR)
- DNLI 1.17
- NBTB 1.04
- MACD
- DNLI 0.23
- NBTB 0.16
- Stochastic Oscillator
- DNLI 90.65
- NBTB 93.70
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About NBTB NBT Bancorp Inc.
NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.